Page 40 - Roche Diagnostics News Today

Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Europe Biopsy Devices Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of...

Three new directors join company board

/PRNewswire/ -- Quarterra Multifamily, a subsidiary of Lennar Corporation and a vertically integrated multifamily apartment builder, developer, and asset...

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay,...

Roche Diagnostics CSF-based tests for Alzheimer’s disease have 90% concordance with Amyloid PET scan

Roche Diagnostics brings on Johnny Smith to lead comms strategy. From PR Week

Increasing popularity of continuous glucose monitoring (CGM) devices in prediabetes and for wellness prompts discussion about appropriate use and points to the need for more data.

/PRNewswire/ -- Capital Digestive Care, the largest private gastroenterology (GI) practice in the Mid-Atlantic region, announced that its new, 22,000 square...

The market for Cell Lysis was valued at $3.45 billion in 2020 and is anticipated to grow at a CAGR of 9.1% between 2023 to 2032.In western and southern blotting for the study of lipids, proteins, and other biomolecules, the technique is frequently combined to damage or denature fragile proteins and DNA. Tumor and ca...

Roche Diagnostics said that their over-the-counter test for SARS-CoV-2 has been rebranded as the Pilot COVID-19 At-Home Test.